GGrantIndex
Sort

17,828 grants matching crispr

Targeting medium chain fatty acid metabolism for the treatment of chronic Graft-versus-Host Disease

$542,119
Hung Nguyen · University Of Central Florida · R01 · FY2024 · HL

Targeting c-Myc stability in c-Myc overexpressing large B-cell lymphoma

$542,063
Lapo Alinari · Ohio State University · R01 · FY2024 · CA

Mechanisms by which the ketone body β-hydroxybutyrate counteracts tau pathogenesis

$541,835
Xu Chen · University Of California, San Diego · R01 · FY2022 · AG

Combined ATR and P13k inhibition in uterine cancer

$541,822
Panagiotis Konstantinopoulos · Dana-Farber Cancer Inst · P01 · FY2025 · CA

Innovative Approaches to Treat Duchenne Muscular Dystrophy Using iPSC-Derived Muscle Progenitors

$541,817
Yao Liang Tang · Augusta University · R01 · FY2017 · AR

Connecting 3D genome misfolding to transcriptional silencing in fragile X syndrome

$541,806
Jennifer Elizabeth Phillips-Cremins · University Of Pennsylvania · R01 · FY2024 · MH

The roles of p53 in embryonic stem cells

$541,591
Jing Huang · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Investigating non-canonical mechanisms of endogenous opioids on motivation in dorsal midbrain

$541,561
Daniel Charles Castro · Washington University · R01 · FY2023 · MH

Engineering Human Heart Tissues with Polyploid Cardiomyocytes

$541,410
Nenad Bursac · Duke University · R01 · FY2022 · HL

Calcium Channels in Glioblastoma

$541,211
Roger Abounader · University Of Virginia · R01 · FY2022 · NS

Regulation of TLR trafficking for proper self versus non-self discrimination

$541,171
Gregory M Barton · University Of California Berkeley · R01 · FY2024 · AI

BET bromodomain inhibition as targeted therapy in acute myeloid leukemia

$541,142
Christopher Vakoc · Cold Spring Harbor Laboratory · R01 · FY2023 · CA

BET bromodomain inhibition as targeted therapy in acute myeloid leukemia

$541,142
Christopher Vakoc · Cold Spring Harbor Laboratory · R01 · FY2022 · CA

CRISPR-Cas13 gene therapy and RNA editing for Facioscapulohumeral muscular dystrophy (FSHD)

$540,811
Scott Q Harper · Research Inst Nationwide Children'S Hosp · R01 · FY2024 · AR

Temporal control of differentiation and epigenetics of Exhausted CD8 T cells by Tox

$540,779
E. John Wherry · University Of Pennsylvania · R01 · FY2024 · AI

Temporal control of differentiation and epigenetics of Exhausted CD8 T cells by Tox

$540,779
E. John Wherry · University Of Pennsylvania · R01 · FY2022 · AI

Temporal control of differentiation and epigenetics of Exhausted CD8 T cells by Tox

$540,779
E. John Wherry · University Of Pennsylvania · R01 · FY2021 · AI

Temporal control of differentiation and epigenetics of Exhausted CD8 T cells by Tox

$540,779
E. John Wherry · University Of Pennsylvania · R01 · FY2023 · AI

Receptor Mediated T and B Cell Activation

$540,649
Richard J. Hodes · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Development and characterization of mouse models of RP59 DHDDS deficiency

$540,536
Steven J Pittler · University Of Alabama At Birmingham · R01 · FY2020 · EY

HNF1A in human endocrine cell development and function

$540,476
Paul J Gadue · Children'S Hosp Of Philadelphia · R01 · FY2020 · DK

Zebrafish core

$540,463
Christine Kettenhofen · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA

Neurotoxicity of Reactive Astrocyte-secreted Lipids in Neurodegenerative Disease

$540,463
Shane Liddelow · New York University School Of Medicine · R01 · FY2023 · EY

Gene-by-environment interactions that affect exposure-mediated congenital heart disease

$540,394
John Andrew Whitehead · University Of California At Davis · R01 · FY2025 · ES

Maintenance and expansion of long-term hematopoietic stem cells

$540,336
Peter S Klein · University Of Pennsylvania · R01 · FY2020 · HL